Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

UPDATE 2-European stocks end week with gains on telecoms, tech boost

Fri, 07th Aug 2020 09:33

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Tech investor Prosus hit by U.S. move on Chinese apps

* Deutsche Telekom boosted by T-Mobile's upbeat Q2 report

* Main regional indexes record weekly gains
(Updates with market close)

By Sruthi Shankar

Aug 7 (Reuters) - European shares closed higher on Friday,
marking weekly gains as investors focused on a broadly
supportive earnings season and improving economic data in
Europe rather than rising U.S.-China tensions.

The main indexes spent the morning in the red after U.S.
President Donald Trump moved to ban U.S. transactions with the
Chinese owners of messaging app WeChat and video-sharing app
TikTok, further escalating friction with Beijing.

Amsterdam-listed Prosus, with its biggest
investment in Tencent, fell 4.0%.

Markets, however, stabilised later, boosted by telecoms
, technology and healthcare stocks.

The pan-European STOXX 600 index, up 0.3%, closed
out with weekly gains of 2%. German stocks rose 0.7%,
while London's FTSE 100 and France's CAC 40 were
flat, but all logged weekly rises.

Data showed U.S. jobs increased by a better-than-expected
1.763 million in July, although the pace of recovery slowed amid
a resurgence in new coronavirus infections, pressuring the White
House and Congress to agree another aid package.

"The jobs numbers were surprisingly good," said Nancy
Tengler, chief investment officer of Laffer Tengler Investments.
"But we expect a moderation in jobs improvement in the near-term
as businesses wait to see what Washington comes up with."

With the bulk of the European earnings season over,
investors were relieved that most companies had exceeded
analysts' much-lowered forecasts for quarterly profits.
Refinitiv data showed about 60% of the STOXX companies that have
reported so far beat estimates.

Hikma Pharmaceuticals jumped 10.9% after saying it
had started manufacturing remdesivir, an approved treatment for
COVID-19 from U.S.-based Gilead, and it raised its
annual sales outlook for two of its biggest divisions.

Deutsche Telekom, which owns 43% of T-Mobile
, rose 2.7% after the U.S. firm added more monthly
subscribers than expected in the second quarter and said it
surpassed rival AT&T.

The broader telecoms index rose 1% to lead sectoral
gains, although stocks considered more sensitive to business
cycles, including banks, miners and oil and gas
companies, handed back some of this week's steady gains.

Standard Life Aberdeen's shares inched higher after
the asset manager said it would pay a dividend even as its
profit dropped 30%.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Arun
Koyyur and Barbara Lewis)

Related Shares

More News
21 Mar 2024 16:33

London close: Stocks rise as BoE keeps rates on hold

(Sharecast News) - London markets closed higher on Thursday, sustaining gains after the Bank of England adhered to expectations by maintaining interes...

14 Mar 2024 15:06

UK dividends calendar - next 7 days

29 Feb 2024 09:18

LONDON BROKER RATINGS: Barclays cuts Direct Line to equal weight

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

29 Feb 2024 07:45

LONDON BRIEFING: Stocks called up following slew of FTSE 100 earnings

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, after a slew of earnings from a range of FTSE 100 companies.

27 Feb 2024 09:40

Berenberg slightly raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing mor...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.